Since May 2008, Dr. Goure has been President and CEO for Acumen Pharmaceuticals.  Dr. Goure has over 20 years of domestic and international experience in the discovery, development, registration, commercial development, and commercialization of chemical and biotechnology products.  

Prior to joining Acumen, Dr. Goure was Vice-President for Commercial Development for Mendel Biotechnology, a bay area company dedicated to creating value through the discovery, development and commercialization of knowledge about plant gene expression.  At Mendel, Dr. Goure negotiated numerous technology collaboration and partnership agreements that generated over $29 million dollars of near term revenues. 

Prior to joining Mendel, Dr. Goure worked for Monsanto Company for 17 years where he developed and commercialized Roundup Ready® soybeans, canola, and cotton.  Dr. Goure was a member of the team that established Monsanto’s quality traits program that led to the Renessen joint (partnership) with Cargill, and was responsible for establishing commercial launch teams in Eastern Europe, South Africa, and Southern Latin America. 

Dr. Goure has a B.S. degree in Chemistry from Fort Lewis College, Durango Colorado, and a Ph.D. degree in organic chemistry from Iowa State University.  Prior to joining Monsanto, Dr. Goure was a Post-Doctoral Fellow at Colorado State University.